US EditionPublished • loading... • Updated
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 4,000 Shares of Stock
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 4,000 Shares of Stock
United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 4,000 shares of the stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $474.64, for a total transaction of $1,898,560.00. Following the completion of the transaction, the chief executive officer directly owned 130 shares in […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
